Inventor · disambiguated record
James David Pancook
Also filed as: PANCOOK JAMES D · PANCOOK JAMES DAVID
10 granted patents·7 pending applications·77 citations·filing 2001–2024
88Inventor score
Files withLILLY CO ELI8ELANCO US INC4APPLIED MOLECULAR EVOLUTION1JONES BRYAN EDWARD1WATKINS JEFFRY D1
Top patents by PatentIndex Score
17 records- 0193US7494651B2TGF-β binding antibodiesLILLY CO ELI·Filed 2006·Granted Feb 24, 2009·27 cites·4 claims
- 0289US7927593B2TGF-beta binding antibodiesLILLY CO ELI·Filed 2010·Granted Apr 19, 2011·15 cites·10 claims
- 0388US10941206B2Chimeric canine anti-CD20 antibodyELANCO US INC·Filed 2019·Granted Mar 9, 2021·2 cites·4 claims
- 0487US11242370B2Neuregulin-4 compounds and methods of useLILLY CO ELI·Filed 2020·Granted Feb 8, 2022·2 cites·8 claims
- 0586US7049121B2Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of useAPPLIED MOLECULAR EVOLUTION·Filed 2002·Granted May 23, 2006·20 cites·10 claims
- 0685US10519244B2Chimeric canine anti-CD20 antibodyELANCO US INC·Filed 2017·Granted Dec 31, 2019·4 cites·10 claims
- 0783US12195548B2Chimeric canine anti-CD20 antibodyELANCO US INC·Filed 2023·Granted Jan 14, 2025·0 cites·7 claims
- 0879US2025092107A1Neuregulin-4 compounds and methods of useLILLY CO ELI·Filed 2024·Application pending·0 cites
- 0973US12145972B2Neuregulin-4 compounds and methods of useLILLY CO ELI·Filed 2021·Granted Nov 19, 2024·0 cites·29 claims
- 1073US11466066B2Variants of human BMP7 proteinLILLY CO ELI·Filed 2018·Granted Oct 11, 2022·2 cites·16 claims
- 1173US6989261B2Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of useLILLY CO ELI·Filed 2003·Granted Jan 24, 2006·5 cites·12 claims
- 1272US2021163618A1Chimeric canine anti-cd20 antibodyELANCO US INC·Filed 2021·Application pending·0 cites
- 1361US2009155285A1Tgf-beta binding antibodiesJONES BRYAN EDWARD·Filed 2009·Application pending·0 cites
- 1457US2006263345A1Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of useWATKINS JEFFRY D·Filed 2004·Application pending·0 cites
- 1550US2005136044A1Butyrylcholinesterase variants that alter the activity of chemotherapeutic agentsFiled 2003·Application pending·0 cites
- 1647US2003153062A1Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of useFiled 2001·Application pending·0 cites
- 1746US2022227860A1Tigit and pd-1/tigit-binding moleculesLILLY CO ELI·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →